This study is in progress, not accepting new patients
Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS
Summary
- Eligibility
- for people ages 18-80 (full criteria)
- Location
- at UC Irvine
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- PTC Therapeutics
- ID
- NCT05349721
- Phase
- Phase 2 Amyotropic Lateral Sclerosis (ALS) Research Study
- Study Type
- Interventional
- Participants
- About 307 people participating
- Last Updated